To investigate whether C/EBP transcription factors and a subset of genes exhibiting LKB1-dependent expression function as tumors suppressors, we integrated CRISPR/Cas9 with tumor barcoding and high-throughput barcode sequencing (Tuba-seq) to assess the impact of inactivating candidate genes on tumor growth42. The gene discussed is STK11; the disease is neoplasm.